New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment, researchers say

Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment, researchers say

byH. Lee Moffitt Cancer Center & Research InstituteCancer cell during cell division. Credit: National Institutes of HealthThe recent U.S. Food and Drug Administration approval of lifileucel,
Oncology August 03,2024
Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment, researchers say

Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment, researchers say

byH. Lee Moffitt Cancer Center & Research InstituteCancer cell during cell division. Credit: National Institutes of HealthThe recent U.S. Food and Drug Administration approval of lifileucel,
Oncology August 03,2024
Long-term results from testicular cancer treatment are positive, study shows

Long-term results from testicular cancer treatment are positive, study shows

byUniversity College CorkCredit: Pixabay/CC0 Public DomainA new study shows that by combining different chemotherapy drugs, testicular cancer remains highly treatable and often curable, even aft
Oncology August 03,2024
Long-term results from testicular cancer treatment are positive, study shows

Long-term results from testicular cancer treatment are positive, study shows

byUniversity College CorkCredit: Pixabay/CC0 Public DomainA new study shows that by combining different chemotherapy drugs, testicular cancer remains highly treatable and often curable, even aft
Oncology August 03,2024
Computational tool integrates transcriptomic data to enhance breast cancer diagnosis and treatment

Computational tool integrates transcriptomic data to enhance breast cancer diagnosis and treatment

by Nik Papageorgiou,Ecole Polytechnique Federale de LausanneClinical validation of EMBER. Credit:npj Breast Cancer(2024). DOI: 10.1038/s41523-024-00665-zAddressing problems with diag
Oncology August 03,2024
Computational tool integrates transcriptomic data to enhance breast cancer diagnosis and treatment

Computational tool integrates transcriptomic data to enhance breast cancer diagnosis and treatment

by Nik Papageorgiou,Ecole Polytechnique Federale de LausanneClinical validation of EMBER. Credit:npj Breast Cancer(2024). DOI: 10.1038/s41523-024-00665-zAddressing problems with diag
Oncology August 03,2024
Ophthalmologic manifestations of acute leukemia are heterogeneous

Ophthalmologic manifestations of acute leukemia are heterogeneous

by Elana GotkineOphthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial presentation or relapse, according to a studypublishedonline July 10 in the&nbsp
Oncology August 03,2024
Ophthalmologic manifestations of acute leukemia are heterogeneous

Ophthalmologic manifestations of acute leukemia are heterogeneous

by Elana GotkineOphthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial presentation or relapse, according to a studypublishedonline July 10 in the&nbsp
Oncology August 03,2024
AI model identifies certain breast tumor stages likely to progress to invasive cancer

AI model identifies certain breast tumor stages likely to progress to invasive cancer

by Adam ZeweA large-scale high-resolution chromatin imaging dataset enables the analysis of disease stages and phenotypic categories in DCIS. Credit:Nature Communications(2024). DOI: 10.10
Oncology August 03,2024
AI model identifies certain breast tumor stages likely to progress to invasive cancer

AI model identifies certain breast tumor stages likely to progress to invasive cancer

by Adam ZeweA large-scale high-resolution chromatin imaging dataset enables the analysis of disease stages and phenotypic categories in DCIS. Credit:Nature Communications(2024). DOI: 10.10
Oncology August 03,2024
DDX41 and its unique contribution to myeloid leukemogenesis

DDX41 and its unique contribution to myeloid leukemogenesis

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainIn an editorial paper published inOncotargettitled, "DDX41 and its unique contribution to myeloid leukemogenesis," researc
Oncology August 03,2024
DDX41 and its unique contribution to myeloid leukemogenesis

DDX41 and its unique contribution to myeloid leukemogenesis

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainIn an editorial paper published inOncotargettitled, "DDX41 and its unique contribution to myeloid leukemogenesis," researc
Oncology August 03,2024
Researchers learn how cancer cells divide despite treatment

Researchers learn how cancer cells divide despite treatment

by Kendall Daniels,University of North Carolina at Chapel Hill School of MedicineResearchers first saw evidence that some cells were escaping arrest in the continued presence of Palbociclib just
Oncology August 03,2024
Researchers learn how cancer cells divide despite treatment

Researchers learn how cancer cells divide despite treatment

by Kendall Daniels,University of North Carolina at Chapel Hill School of MedicineResearchers first saw evidence that some cells were escaping arrest in the continued presence of Palbociclib just
Oncology August 03,2024
Research points the way toward an exhaled-breath test for lung cancer

Research points the way toward an exhaled-breath test for lung cancer

by Hackensack Meridian HealthOlivier Loudig, Ph.D., of the Hackensack Meridian Center for Discovery and Innovation (CDI). Credit: Hackensack Meridian HealthThe foundational science to develop an exhal
Oncology August 03,2024
Research points the way toward an exhaled-breath test for lung cancer

Research points the way toward an exhaled-breath test for lung cancer

by Hackensack Meridian HealthOlivier Loudig, Ph.D., of the Hackensack Meridian Center for Discovery and Innovation (CDI). Credit: Hackensack Meridian HealthThe foundational science to develop an exhal
Oncology August 03,2024
Findings reveal unexpected role of protein OTX2 that drives aggressive medulloblastoma

Findings reveal unexpected role of protein OTX2 that drives aggressive medulloblastoma

byBaylor College of MedicineCredit: Unsplash/CC0 Public DomainIn a reportpublishedinNature Cell Biology, researchers at Baylor College of Medicine, Texas Children's Hospita
Oncology August 03,2024
Findings reveal unexpected role of protein OTX2 that drives aggressive medulloblastoma

Findings reveal unexpected role of protein OTX2 that drives aggressive medulloblastoma

byBaylor College of MedicineCredit: Unsplash/CC0 Public DomainIn a reportpublishedinNature Cell Biology, researchers at Baylor College of Medicine, Texas Children's Hospita
Oncology August 03,2024
And improved method for anti-cancer drug detection: How tiny tumor models could transform drug testing

And improved method for anti-cancer drug detection: How tiny tumor models could transform drug testing

by Songshan Lake Materials LaboratorySchematic of microfluidic chip-based approach for quality assessment and screening of esophageal cancer drugs. A three-dimensional scaffold with inverse opal struc
Oncology August 03,2024
And improved method for anti-cancer drug detection: How tiny tumor models could transform drug testing

And improved method for anti-cancer drug detection: How tiny tumor models could transform drug testing

by Songshan Lake Materials LaboratorySchematic of microfluidic chip-based approach for quality assessment and screening of esophageal cancer drugs. A three-dimensional scaffold with inverse opal struc
Oncology August 03,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com